Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa D Chengalroyen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pathogens (Basel, Switzerland)|November 25, 2023
Current Perspectives and Challenges of MAIT Cell-Directed Therapy for Tuberculosis InfectionMelissa D Chengalroyen
Frontiers in Immunology|February 2, 2026
Flavin and deazaflavin biosynthesis in mycobacteria: relevance to physiology, implications for drug discovery, MR-1 antigenicity, and vaccine developmentNurudeen Oketade, Melissa D Chengalroyen, Dylan Kain, et al.
Frontiers in Cellular and Infection Microbiology|December 12, 2022
The detection of mixed tuberculosis infections using culture filtrate and resuscitation promoting factor deficient filtrateMelissa D Chengalroyen, Germar M Beukes, Kennedy Otwombe, et al.
Frontiers in Cellular and Infection Microbiology|December 7, 2020
Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Audrey Jordaan, Ronnett Seldon, et al.
ACS Infectious Diseases|April 28, 2026
Beyond Inhibition: Sublethal Rifampicin-Induced Molecular Adaptations Confer Phenotypic Drug Tolerance in MycobacteriaBlake D Stuart, Anja van der Merwe, Melissa D Chengalroyen, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 2016
Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with TuberculosisMelissa D Chengalroyen, Germar M Beukes, Bhavna G Gordhan, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Modulation of riboflavin biosynthesis and utilization in mycobacteriaMelissa D Chengalroyen, Carolina Mehaffy, Megan Lucas, et al.
Microbiology Spectrum|June 25, 2024
Modulation of riboflavin biosynthesis and utilization in mycobacteriaMelissa D Chengalroyen, Carolina Mehaffy, Megan Lucas, et al.
ACS Infectious Diseases|February 10, 2022
DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Mandy K Mason, Alessandro Borsellini, et al.
Plos Pathogens|July 1, 2025
Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonistsMelissa D Chengalroyen, Nurudeen Oketade, Aneta Worley, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pathogens (Basel, Switzerland)|November 25, 2023
Current Perspectives and Challenges of MAIT Cell-Directed Therapy for Tuberculosis InfectionMelissa D Chengalroyen
Frontiers in Immunology|February 2, 2026
Flavin and deazaflavin biosynthesis in mycobacteria: relevance to physiology, implications for drug discovery, MR-1 antigenicity, and vaccine developmentNurudeen Oketade, Melissa D Chengalroyen, Dylan Kain, et al.
Frontiers in Cellular and Infection Microbiology|December 12, 2022
The detection of mixed tuberculosis infections using culture filtrate and resuscitation promoting factor deficient filtrateMelissa D Chengalroyen, Germar M Beukes, Kennedy Otwombe, et al.
Frontiers in Cellular and Infection Microbiology|December 7, 2020
Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Audrey Jordaan, Ronnett Seldon, et al.
ACS Infectious Diseases|April 28, 2026
Beyond Inhibition: Sublethal Rifampicin-Induced Molecular Adaptations Confer Phenotypic Drug Tolerance in MycobacteriaBlake D Stuart, Anja van der Merwe, Melissa D Chengalroyen, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 2016
Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with TuberculosisMelissa D Chengalroyen, Germar M Beukes, Bhavna G Gordhan, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Modulation of riboflavin biosynthesis and utilization in mycobacteriaMelissa D Chengalroyen, Carolina Mehaffy, Megan Lucas, et al.
Microbiology Spectrum|June 25, 2024
Modulation of riboflavin biosynthesis and utilization in mycobacteriaMelissa D Chengalroyen, Carolina Mehaffy, Megan Lucas, et al.
ACS Infectious Diseases|February 10, 2022
DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Mandy K Mason, Alessandro Borsellini, et al.
Plos Pathogens|July 1, 2025
Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonistsMelissa D Chengalroyen, Nurudeen Oketade, Aneta Worley, et al.
Pageof 1